MRVI (MRVI) Stock Price & Analysis
MRVI (MRVI) fell 0.68% to USD 7.32 as of September 8, 2026 at 05:46 UTC, according to Nexqual real-time market data.
MRVI last closed at USD 7.32; the session ranged USD 7.17–7.44 on volume of 1,552,057 shares. Market capitalization is —, with a 52-week range of USD 2.42–9.42 (NMS). Source: Nexqual, September 8, 2026 at 05:46 UTC.
Key Statistics (as of September 8, 2026 at 05:46 UTC)
| Price | USD 7.32 |
|---|---|
| Change | ▼ 0.68% (down) |
| Previous Close | USD 7.32 |
| Open | USD 7.32 |
| Day Range | USD 7.17 – 7.44 |
| 52-Week Range | USD 2.42 – 9.42 |
| Volume | 1,552,057 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (MRVI)
Nexqual's technical model rates MRVI "BUY" based on 4 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 05:46 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 49.27 (neutral) |
| vs SMA50 | Above (USD 6.78) |
| MACD | 0.3 (positive) |
From MRVI's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SHC | Sotera Health Company | USD 18.9 | ▼ 0.32% |
| CERT | Certara, Inc. | USD 7.94 | ▼ 4.11% |
| SEER | Seer, Inc. | USD 1.95 | ▼ 1.52% |
| CCCC | C4 Therapeutics, Inc. | USD 3.76 | ▼ 0.79% |
| BCAB | BioAtla, Inc. | USD 1.74 | ▲ 43.98% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:46 UTC. This page is informational and not investment advice.